The Conviction Spectrum
Every committee asks which way to lean. The harder question, and the one that actually determines outcomes, is how much the lean should weigh.
11 min read | By the team at Banyantree Investment Group
Two components, one instrument: the spike fixes the centre and the blade marks the arc. Each decision requires its own tool. Beam compass, Alteneder & Sons, c. mid-20th century. CIA image archive. Cropped, redrawn, and colour-treated.
───
In the autumn of 1981, Ray Dalio was thirty-two years old and certain. Not cautiously certain. Not hedgedly certain. Certain in the way that allows a person to testify before the United States Congress and hear themselves speak without any trace of doubt. His research had led him to a conclusion that felt as close to arithmetic as analysis gets: the Federal Reserve had engineered a period of tight money, the world’s borrowing nations had accumulated debts they could not repay, and the only two responses available, default or inflation, would both be devastating. A depression was coming. He wrote about it in newspaper columns. He appeared on television to say so. He told Congress.
In August 1982, Mexico defaulted on its sovereign debt. The cascade he had predicted had begun. He was, by any reasonable measure, right.
And then Paul Volcker lowered interest rates and opened the liquidity taps, and the market did something Dalio had rated as improbable: it turned. The S&P 500 began a rally that would compound for nearly two decades. The greatest non-inflationary bull market in American history started almost exactly where Dalio had announced it would end.
He lost almost everything. He dismissed all of his employees until Bridgewater Associates consisted of one person: Dalio. He borrowed four thousand dollars from his father to cover his family’s bills. The experience, he would later write, was like being hit in the head with a baseball bat.
What had failed was not the underlying analysis. The debt was real. The default was real. His reading of the structural problem was, by most accounts, largely correct. What failed was the portfolio’s dependence on a thesis that needed to be right not just directionally, but in every important detail, including the policy response that Dalio had examined and dismissed. He had made a single, decisive mistake: he had confused the quality of his analysis with the completeness of his knowledge.
───
There is a question that gets asked in investment committee rooms so often, and in so many variations, that it has become a kind of institutional reflex. It goes like this: are we bullish or bearish? Risk on or risk off? Constructive or cautious? The question is not unreasonable. Portfolios must be positioned somehow, and a direction, towards risk or away from it, seems like a logical place to start.
The trouble is that this question contains a hidden second question, and the hidden question is the one that actually determines outcomes. Not: in which direction should we lean? But: how much should that lean weigh?
Direction and size are two separate decisions. Most of the error in professional investing lives in treating them as one.
The Sequoia Fund made this error in the other direction. Founded in 1970 by Bill Ruane, with Warren Buffett’s explicit blessing when he closed the Buffett Partnership and directed his departing partners towards Ruane’s care, Sequoia had spent forty-five years building one of the most admired records on Wall Street. Over that period it earned an annualised return of 14.65 per cent, outperforming the S&P 500 in 332 of 333 rolling ten-year windows. Its method was deliberate, long-horizon, concentrated. By mid-2015, Valeant Pharmaceuticals had grown to represent 32 per cent of the fund’s assets. Not through carelessness. Not through leverage. Through conviction: a thesis that was coherent, a stock that had been rising for years, and a management team that had not yet been caught.
When Valeant eventually imploded under the weight of its drug pricing practices, a pharmacy subsidiary scandal, and the regulatory attention that followed, it lost 93 per cent of its value from peak to trough. Sequoia fell 34 per cent over the same period, lagging the S&P 500 by 31 percentage points. Robert Goldfarb, CEO and co-manager for forty-five years, resigned. The fund was sued by its own shareholders. “That’s where we got in trouble,” co-manager David Poppe said afterward. “Where Bob said, ‘I’m right and you guys are wrong.’”
The direction was not obviously wrong. The sizing was fatal.
Dalio had bet everything on a macro scenario. Goldfarb had bet everything on a single stock. The mechanisms were different. The root error was identical: each had allowed conviction to collapse into certainty, and certainty into size.
───
Buried inside the Dalio story is a distinction he spent the next several decades building Bridgewater around.
Some of what goes into a thesis is knowable, not with perfect precision, but with genuine analytical grounding. Balance sheet strength is observable. Cash generation is measurable. Competitive position can be examined, stress-tested, and updated as evidence arrives. Valuation can be assessed against a range of outcomes. These inputs can be evaluated. They provide a foundation.
What cannot be known, in any serious sense, is the set of contingent facts that surround them: the timing of when a thesis resolves, the policy decisions of central banks operating under pressure, the regulatory attention that will eventually fall on a particular business model, the competitor response that is still being planned in another building. Dalio knew about the debt. He did not know how Volcker would respond to it. Sequoia understood Valeant’s model. They did not know about the pharmacy subsidiary, or the precise combination of congressional scrutiny and accounting restatements that would destroy investor confidence in a single season.
This distinction, between what a thesis can know and what it cannot, is the engine inside a non-binary portfolio.
The knowable supports a direction. It gives grounds for wanting exposure, for finding a thesis worth holding. The unknowable constrains the size. It sets a ceiling on how much of the portfolio a single set of assumptions can control. The unknowable is not a temporary condition to be resolved with more research. It is structural: the gap between analysis and outcome that exists in every investment, at every conviction level, regardless of how thoroughly the knowable has been examined. Acknowledging it is not timidity. It is precision.
Plan for what we know. Plan, also, for what we cannot.
───
The practical question is how to convert that distinction into portfolio construction without turning every sizing decision into an abstract epistemology exercise. The answer is to let position size follow the quality of the evidence.
A position where the evidence is clear, the downside is bounded, and the thesis holds across most of the scenarios that matter earns a larger weight: not because nothing can go wrong, but because the portfolio is being built to absorb the possibility that something will. A position where the direction is clear but something important remains unresolved, where one or two reporting periods or a single data point would sharpen the picture considerably, earns a smaller weight: genuine exposure to a thesis worth holding, sized to reflect that something important is still being established rather than assumed. A position where the material unknowns dominate the range of plausible outcomes earns a minimal allocation, functioning primarily as optionality: a real position in an idea that may deserve more capital when the picture clarifies. And then there are positions to avoid altogether, not because the idea lacks merit, but because the gap between what is knowable and what is required cannot be sized safely within any sensible loss budget.
Conviction sets size. Uncertainty sets diversification.
Diversification spread across positions where conviction has not been earned is not a slogan or a comfort blanket. It is an acknowledgement of what the portfolio does not yet know, deployed deliberately rather than sprayed indiscriminately. A portfolio of positions held at equal weight regardless of evidence quality is not diversified. It is indifferent. A portfolio where the largest positions carry the most robust evidence, and the smaller positions carry the most uncertainty, is doing something more considered: it is allowing the knowable to set the hierarchy.
Concentration is not the opposite of this discipline. It is the product of it. Concentration is earned; diversification is used where conviction is not.
Exhibit 1 : The Conviction Spectrum — Definitions and Sizing Constraints
Conviction is not a personality trait. It is a funding decision under uncertainty. The point of the spectrum is to make that decision explicit, and to stop pretending that “maybe” and “yes” should be sized the same. Illustrative and hypothetical.
───
Take three positions a portfolio team might hold simultaneously.
The first is a payments infrastructure business with a network effect that has compounded for two decades: the more merchants and financial institutions that use the settlement system, the more valuable it becomes to each participant. Gross margins above 80 per cent. Revenue retention that has held above 105 per cent in every measured year. The valuation is full by most conventional measures, but the thesis holds across most of the scenarios that matter, including a recession, a technology disruption, and a round of regulatory scrutiny. The downside in a genuine stress case is bounded: a business that processes transactions survives any environment in which commerce continues. The unknowns are real, regulatory change and a technology transition among them, but none dominates the range of plausible outcomes. This position earns a weight near the top of the sizing range.
The second is a consumer staples business with durable brand advantages whose margin structure has been compressed by three years of elevated input costs. The competitive position is not in doubt. What is not yet established is the recovery timeline: whether margins normalise over the next two reporting periods or over the next two years. The direction is clear. The specific path is not. This position earns a smaller weight: enough to benefit meaningfully if the thesis resolves as expected, sized to reflect that something important is still being demonstrated rather than assumed.
The third is an early-stage industrial business developing proprietary water treatment technology for industrial use. The product works at small scale. The addressable market is genuinely large. The thesis requires a contract from a major industrial operator, a decision that will either confirm a commercial pathway or reveal that adoption is slower and more expensive than the model assumes. The direction may well be right. The entire outcome depends on something that analysis can inform and cannot determine. This position earns a minimal weight, functioning as optionality: a real position in an idea that may deserve substantially more capital when the picture clarifies, and one the portfolio can hold without damage if it does not.
───
Exhibit 2 : Three Holdings, Three Conviction Levels, Three Weights
Three hypothetical holdings sized to the quality of available evidence: highest weight where the thesis holds across most scenarios, lowest where a single unresolved variable dominates the range of outcomes. Hypothetical. Illustrative only. Not financial advice.
The portfolio that results is not cautious. The first position is meaningful precisely because the evidence warrants it. The second and third are held at weights that reflect what is actually known, not what is hoped. Together they express genuine views, without requiring those views to be entirely right.
───
What would change this view?
Three challenges deserve more than a dismissal.
The first: the framework assumes conviction can be accurately calibrated at a point in time. But conviction can collapse on new information faster than a position can be adjusted. Valeant’s model looked knowable to the Sequoia team for years. The pharmacy subsidiary was not. A position sized for high conviction yesterday can be structurally oversized tomorrow, not because the sizing framework failed, but because it was calibrated to an understanding of the knowable that turned out to be incomplete. The discipline addresses the sizing error. It relies on the same human judgement system that produces the original mis-categorisation of what is truly known.
The second: graduated sizing requires ongoing and accurate judgement about where each position sits on the conviction spectrum. If that judgement is subject to the same biases as original position-taking, anchoring to the thesis, overweighting recent confirming evidence, underweighting emerging contrary signals, the graduated framework produces similar outcomes to unconstrained concentration, with better-sounding language. The process works when the conviction spectrum is assessed honestly and updated continuously. The question is whether the governance structures that apply this framework create the conditions for that honesty, or merely provide a vocabulary for rationalising existing positions at whatever size they happen to be.
A third challenge is structural. Some mandates are constrained in ways that make fine graduation impractical. A fund with narrow weight limits, high minimum position counts, or strict liquidity rules cannot always express a four-tier conviction spectrum neatly. Where the implementation levers are limited, the principle must be adapted rather than abandoned. Conviction still matters, but it may need to be expressed through narrower weight bands, higher liquidity, or a greater number of positions diversifying a thesis whose central unknowns remain large.
All three deserve acknowledgement. A framework that asks conviction to set size must also ask whether conviction is being judged honestly, updated quickly enough, and translated into a mandate that can actually express it.
───
After 1982, Dalio rebuilt Bridgewater around a principle he later articulated as fifteen good uncorrelated return streams. He did not stop having views. He did not become uncertain about everything. He stopped needing his views to be entirely right in order for the portfolio to survive.
Direction is one decision. Size is another.
A portfolio that requires its convictions to be right is not a portfolio. It is a bet.
───
General information only. Not personal advice. Past performance is not indicative of future performance. Examples are illustrative and hypothetical. This material is intended for wholesale and professional investors.
